Company intelligence / Profile preview

Cryos International

Ownership: Private
Employees: ~170
Development stage: Commercial

Overview

Cryos International is the world’s largest sperm and egg bank, providing extensively screened donor sperm and eggs to individuals and fertility clinics in over 100 countries. The company has more than three decades of experience, holds all relevant regulatory licenses (including FDA, Health Canada), operates ISO-certified labs, and partners with a global network of fertility clinics. Its clinical results are measured by successful pregnancies achieved through its products[1][2][3][4].

Therapeutic areas: EndocrinologyWomen's Health
Modalities: Non-pharmacological therapy (donor gametes for assisted reproduction)
Industry: Non-Drug Biotech

Partnerships

Cryos collaborates with numerous fertility clinics worldwide but does not list specific major pharmaceutical or biotech partnerships

Beyond the preview

Go deeper on Cryos International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryos International.

Explore the full profile